# PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers

> **NCT07730671** · — · NOT_YET_RECRUITING · sponsor: **Barcelonabeta Brain Research Center, Pasqual Maragall Foundation** · enrollment: 121 (estimated)

## Conditions studied

- Subjective Cognitive Decline (SCD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07730671
- **Lead sponsor:** Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-09
- **Final completion:** 2028-09
- **Target enrollment:** 121 (ESTIMATED)
- **Last updated:** 2026-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730671, "PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*